Introduction
The retinoblastoma gene (RB1), located on chromosome 13q14 in the human genome, encodes a 928 animo acid nuclear phosphoprotein (pRb) (Fung et al., 1987; Lee et al., 1987; McGee et al., 1989; T'Ang et al., 1989) . Mutations within RB1 which lead to an inactivation of the gene product or deletions of RB1 have been found to play a role in the etiology or progression of a variety of human cancers in tissues derived from all three germ layers, most notably the childhood ocular cancer retinoblastoma (Ahuja et al., 1991; Cavenee et al., 1983 Cavenee et al., , 1985 Chen et al., 1990; Cryns et al., 1993; Dunn et al., 1988; Friend et al., 1986 Friend et al., , 1987 Fung et al., 1987; Fung and T'Ang 1992; Gallie 1994; Ginsberg et al., 1991 Ginsberg et al., , 1992 Horowitz et al., 1990; Ishikawa et al., 1991; Kato et al., 1994; Kloss et al., 1991; Lee et al., 1988; Li et al., 1991; Meling et al., 1991; Murakami et al., 1991; Nakamura et al., 1991; Reissmann et al., 1989; Sarkar et al., 1992; Weide et al., 1991; Yamaguchi et al., 1996) . Reintroduction of a wildtype RB1 cDNA into certain tumor cell lines which lack functional pRb can reverse the transformed phenotype (Antelman et al., 1995; Banerjee et al., 1992; Huang et al., 1988; Uzvolgyi et al., 1991; Xu et al., 1991) , providing further evidence that RB1 acts as a tumor suppressor. pRb is involved in negative regulation of the cell cycle, thus acting as a control of cellular proliferation. This regulation of cellular proliferation is dependent on the ability of pRb to bind to cellular transcription factors. One such transcription factor is E2F, which has been shown to be important in the control of cellular proliferation (Arroyo and Raychaudhuri, 1992; Bagchi et al., 1991; Chellappan et al., 1991; Chittenden et al., 1991; Hiebert et al., 1992; Nevins et al., 1991; Thalmeier et al., 1989) . pRb has also been shown to bind to and inhibit the activity of other cellular factors which enhance or stimulate transcription. These factors include c-Abl (Welch and Wang, 1993) , UBF (Cavanaugh et al., 1995) , PU.1 (Hagemeier et al., 1993) , Elf-1 , SP-1, SP-3 (Udvadia et al., 1995) .
In addition to its role in transcriptional repression, studies have shown that pRb also has a role in transcriptional activation. Kim et al. have demonstrated that pRb can activate transcription of the human TGFb2 gene (Kim et al., 1992) and also that pRb can positively regulate Sp1 transcriptional activity through binding to TAFII250 (Shao et al., 1995) . Singh et al. have demonstrated a direct interaction between pRb and hBrm which resulted in a stimulation of glucocorticoidreceptor-mediated transcription (Singh et al., 1995) . This stimulation was due to an enhancement of the activity of hBrm after binding to pRb, demonstrating that pRb is not limited to a role of inactivation by binding.
As evidenced by its role in tumor formation, absence of functional pRb may result in uncontrolled cellular proliferation. However, absence of functional pRb may also lead to apoptosis, as demonstrated by mouse model systems. Mice homozygously deleted for the wildtype RB1 allele appeared grossly normal until day 12.5 post coitus (pc), but by day 14.5 pc the nullizygotes died. Closer observation revealed abnormalities in the liver and hindbrain, areas which exhibited high levels of RB1 expression in the developing mouse embryo as determined by in situ staining of whole mount embryos (Szekely et al., 1992) . Aberrant erythropoiesis in the liver, as evidenced by the appearance of nucleated mature red blood cells, signi®ed a disruption in dierentiation (Clarke et al., 1992) . There was also increased cell death by apoptosis in the spinal cord and portions of the hindbrain (Clarke et al., 1992; Jacks et al., 1992) . Closer examination of the eye of the nullizygotes showed unregulated cellular proliferation, disruption of dierentiation, and excessive apoptosis in lens ®ber cells (Morgenbesser et al., 1994) . In addition, ®broblasts cultured from the nullizygous RB1 mice were similar in growth rate and morphology to ®broblasts from either an RB1 +/+ or RB1 +/7 embryo under growth permissive conditions; however, altering the cellular environment to growth limiting conditions resulted in induction of apoptosis in the RB1 7/7 cells while the cells which contained at least one copy of normal RB1 underwent growth arrest (Almasan et al., 1995) . This suggests that apoptosis is a potential phenotypic consequence of pRb loss, and that the consequence of loss of pRb is dependent on both cell type and cellular environment.
The pRb protein can be divided into at least four distinct functional domains as de®ned by protein binding (Figure 1a ). Two regions, 'A' and 'B', separated by a spacer region, form the A/B pocket domain which has been de®ned as the minimal region of pRb required to bind to the viral oncoproteins Adenovirus E1A, Human Papilloma virus E7, and SV40 Large T antigen (Chellappan et al., 1992; Chow and Dean, 1996; Hu et al., 1990) . Mutations within this A/B pocket which prevent binding of these oncoproteins to pRb also render the pRb protein nonfunctional (Hu et al., 1990) , suggesting that this pocket is also required for binding of endogenous cellular proteins. Though the identity of the exact amino acids in pRb required for binding to these proteins is unknown, the viral oncoproteins all share a 5 amino acid sequence, LXCXE, which is necessary for binding to pRb (Defeo-Jones et al., 1991) . Several cellular proteins have been identi®ed which contain this LXCXE motif and are able to bind to the A/B pocket region of pRb. These include the D cyclins (Dowdy et al., 1993; Ewen et al., 1993; Kato et al., 1993) , Protein Phosphatase Type 1a (Durfee et al., 1993) , PU.1 (Hagemeier et al., 1993) , UBF (Cavanaugh et al., 1995) , Elf-1 , and RB1 Binding Proteins 1 and 2 (DefeoJones et al., 1991; Fattaey et al., 1993) .
A truncated RB1 composed of the A/B pocket and the C-terminus, which now includes the E2F-binding region (Huang et al., 1992) , is able to act as a functional domain in the absence of the N-terminal region. Overexpression of the full length pRb in Saos-2 cells arrested these cells in G 1 and produced a large, at cell morphology. Expression of the A/B+C fragment alone was also sucient to produce the same phenotype (Goodrich et al., 1991) , and thus is referred to as the growth-suppressive domain.
The C-terminal pocket domain has been shown to bind both c-Abl (Welch and Wang, 1993) and mdm2 (Xiao et al., 1995) . This binding region is distinct from the sequence needed for E2F binding, and it is possible to form a complex containing both E2F or cyclin D2 Figure 1 (a) Map of RB1 cDNA and its binding domains. Below the protein map are regions that have been implicated in speci®c protein interactions. A/P alanine-proline rich region, CC ± coiled coil protein motif, NES ± nuclear export motif, CK ± casein kinaseII phosphorylation recognition site, LZ ± leucine zipper motif, HLH putative helix ± loop ± helix motif, NLS ± nuclear localization signal motif. The serine/threonine phosphorylation sites are denoted by ®lled circles at sites of known phosphorylation and by open circles at possible sites of phosphorylation. (b) Schematic representation of wt-pRb and pRb-domain constructs. Each construct contained the pRb amino acid sequences indicated, with the addition of an ATG-Start codon in the N-terminally truncated mutants, or a TAG-termination codon in the C-terminally truncated mutant. Each mutant is designated by the pRb domain it contains. *=FLAG-epitope tag and c-Abl bound to pRb simultaneously (Welch and Wang, 1995) . This simultaneous binding denotes at least two distinctly separate protein interaction domains within pRb. In addition to the protein binding domain, the C-terminus also includes a bipartite nuclear localization signal (NLS) (Zacksenhaus et al., 1993) .
The N-terminal region 5' to the A/B pocket, though not required for Saos-2 cell growth arrest, does play a role in pRb function, as mutants which have a disrupted N-terminal domain have been found to be nonfunctional (Hogg et al., 1993; Qian et al., 1992) . Recent evidence has found that pRb-mediated Sp1-dependent stimulation of expression of the human Insulin Receptor (hIR) is abrogated by deletions in the N-terminus of pRb and within the internal A/B spacer region, but is not dependent on regions in the A/B pocket or Cterminus (Shen et al., 1995) . This stimulation is not due to a direct interaction between pRb and Sp1, but may be through binding to TAFII250 (Shao et al., 1995) . The N-terminus also has other protein binding abilities and has been shown to bind to the nuclear matrix protein p84 (Durfee et al., 1994) and to a novel cell cycle regulated kinase (Sterner et al., 1995) . Welch and Wang (1995) demonstrated that the Cterminal pocket of pRb, when co-expressed with wildtype (wt)pRb in Saos-2 cells, could disrupt the function of the wtpRb, as assayed by the reduction in the number of¯at cells produced. The present study addresses the question: can separate domains of the pRb protein disrupt pRb function in cells which contain endogenous wtpRb, and if so, what is the consequence to these cells of loss of pRb function?
Results

Localization and phenotype of the pRB mutants by transient transfections
Three RB1 mutant constructs consisting of the three major domains (N-terminus, A/B pocket, C-terminus) were chosen for testing ( Figure 1b) . Initial experiments using a constitutive promoter failed to produce stable cell lines expressing any of the mutant proteins. However, transient transfections of the dierent mutants and immuno¯uorescence detected the presence and localization of the recombinant proteins ( Figure 2 ).
Expression of either A/B or N-NLS produces a phenotype
Suspecting that the inability to generate stable clones for particular mutants was due to the potential deleterious eect of the expressed mutant proteins, we developed clones in which expression of the mutant proteins was controlled by the inducible metallothioneine promoter. These constructs were co-transfected into Mv1Lu cells with a vector which conferred hygromycin-resistance. After 3 weeks of hygromycin selection, which began 2 days post-transfection, the clones of each transfection were pooled, expanded to con¯uence, and expression of the mutants was induced by switching the cells to low serum (0.2% FBS) media containing ZnCl 2 . Using low serum conditions not only reduced the competition between cell signals by removing growth factors from the media and thus promoting cell cycle exit but also enhanced the induction of expression from the metallothionein promoter.
In both the A/B and N-NLS plates, small areas of dead cells began to appear microscopically as early as 60 h post-induction. By 72 h, grossly visible areas of cellular absence appeared on the plate, with many dead cells¯oating in the media. By 96 h, the plate was cleared of greater than 70% of the attached cells. This cell death can be visualized microscopically following staining of these cell cultures with crystal violet. As can be seen in Figure 3 , the induced A/B and N/NLS show reduced numbers of cells. Plates containing the C and N-terminal mutants as well as the full length wildtype RB remained con¯uently adherent for at least 120 h post induction.
Cell death phenotype is competitively inhibited by wildtype pRb
To dierentiate between gain-of-function versus a dominant interfering activity, the cells were subjected Figure 2 Immunohistochemistry of the various transfected RB constructs. Each construct was transfected into Mv1Lu cells and after 48 h was ®xed and stained for the presence of the transfected RB1 construct using either anti-pRb or anti-FLAG antibody and counterstained with Hoechst dye to stain the nuclei blue. The sensitivity of this method is such that only the overexpressed protein is detected.
(1) Wildtype RB1 construct, (2) A/B+C, (3) C, (4) A/B, (5) N, (6) N-NLS to the classic experiment that de®nes dominantnegative activity: rescue of the phenotype by coexpression of the wildtype protein (Herskowitz, 1987) . Co-transfection of a constitutively expressed wildtype pRb on a vector containing the drug selectable marker hygromycin (pEB-Rb) with the inducible A/B or N-NLS mutant constructs in a 1 : 4 wildtype-to-mutant ratio was sucient to prevent the cells from undergoing apoptosis, as compared to a control cotransfection utilizing the vector without pRb in place of the wildtype construct (Figure 4a ). Western analysis con®rmed expression of both wildtype and mutant proteins in the dually-transfected cells (Figure 4b ).
Phenotype resulting from expression of RB mutant constructs A/B and N-NLS is apoptosis
To verify that the phenotypic response was indeed apoptosis and not necrosis, DNA was extracted from transfected cells and subjected to electrophoresis on an agarose gel to visualize DNA laddering, a biochemical hallmark of apoptosis. Laddering is the result of internucleosomal cleavage of the DNA, resulting in DNA fragments corresponding in size to multimers of 180 bp (Wyllie, 1992) . Cells containing the A/B mutant, the N-NLS mutant or the C-terminal mutant were induced as in the previous experiment and the cells were harvested at 60, 72, and 96 h post-induction.
As controls, 96 h non-induced cell cultures of both C and A/B were also harvested. The cells were collected from both the media and the adherent layer and pooled prior to DNA extraction. As shown in Figure  5 , DNA laddering was seen in the induced A/B and N-NLS populations, but not in either the uninduced populations or the induced C-terminal populations. Indeed, laddering was seen as early as the 60 h stage, when cell death is detected only at the microscopic level, prior to the media ®lling with dead cells.
Discussion
pRb plays a role in cell cycle regulation and is required in multiple cellular processes. pRb function is dependent on the ability of pRb to bind to cellular factors, and this is facilitated by multiple proteinbinding domains with pRb. Disruption of the ability of pRb to bind to cellular factors leads to a loss of pRb function, which can lead to uncontrolled cellular proliferation; however, uncontrolled proliferation is not a universal response to pRb inactivation. The ultimate cellular response to the loss of pRb is dependent on cellular context. Our experiments tested the ability of pRb domains to disrupt wildtype pRb function within a tissue culture system in which apoptosis was the resulting phenotype. Introduction of wildtype pRb produced no discernable gross phenotype in Mv1Lu cells. Introduction of the Nterminus or the C-terminal mutant also produced no phenotype. However, both the A/B and N-NLS mutants were able to induce a phenotype under the assay conditions, which suggests that these mutants can act as dominant disruptors of wildtype pRb function. Dominant negative mutants are able to abrogate the function of the wildtype protein in the presence of the wildtype protein, mimicking a loss-of-function phenotype (Herskowitz, 1987) . Loss of pRb function in the absence of additional genetic lesions can lead to apoptosis, as was seen in the RB-nullizygous mouse ocular lens, hindbrain, and cultured ®broblasts. Introduction of the A/B or N (combined with a NLS) fragments of pRb into Mv1Lu was sucient to induce death under growth limiting conditions. Dominant negative mutants are distinguished from gain-of-function mutants by competition with excess wildtype protein: excess wildtype protein is able to abrogate the phenotype produced by the dominant negative mutant but has no eect on the phenotype produced by a gain-of-function mutant. Co-expression of excess wildtype pRb with the A/B or N-NLS mutant was able to prevent the apoptotic phenotype induced by the RB1 mutants ( Figure 5) . Therefore, the A/B pocket fragment and the N-terminus (when combined with a NLS) of pRb are able to act as dominant negative mutants of the wildtype pRb. Welch and Wang (1995) demonstrated that the Cterminal fragment of pRb was able to disrupt the function of wildtype pRb in Saos-2 cells, a cell line which lacks both wildtype pRb and p53. Reintroduction of wildtype pRb produced a large¯at cell morphology with reduced numbers of colonies. Cotransfection of either the C-terminus or an A/B pocket construct with wildtype pRb resulted in a decreased number of¯at cells and an increase in colony number after 14 days of drug selection, whereas transfection of the C or A/B constructs without wildtype pRb resulted in colony numbers consistent with vector alone. The phenotype was a reduced number of¯at cells but not apoptosis, which demonstrates that apoptosis due to interruption of pRb function is not a universal tissue culture phenomenon, and that cellular context and genetic environment play signi®cant roles. The Cterminus was able to disrupt the pRb-E2F complex as was shown by gel shift assay, which should theoretically introduce unregulated E2F in the system. Since apoptosis by E2F-overexpression has been demonstrated to be p53 dependent (Wu and Levine, 1994) , perhaps the absence of p53 in the Saos-2 cells contributed to cell survival in the absence of pRb. The use of DSE, a C-terminal construct which did not disrupt wildtype pRb-E2F interactions but did prevent at cell morphology in the Saos-2 assay, demonstrated that unregulated E2F is not the only mechanism of action which can produce this phenotype (Welch and Wang, 1995) . Similarly, it is unlikely that the Nterminal mutant would disrupt the pRb-E2F complex as the N-NLS mutant contains only a minimal portion of the A pocket. Additionally, since the C-terminal construct which is capable of disrupting the pRb-E2F complex, was unable to produce a phenotype in the Mv1Lu assay, the release of E2F does not appear to be solely sucient to produce the apoptotic response in Mv1Lu cells. This does not rule out the possibility that E2F is playing a role in the apoptotic response to the RB1 mutants; it simply suggests that the mechanism of action has additional complexity. It is tempting to speculate that both the A/B and N-NLS mutants are acting by competitively binding to dierent proteins and therefore preventing pRb from being able to form functional complexes. However, the exact nature of the mechanism of action of these mutants is currently unknown.
Although Saos-2 cells, due to their extreme sensitivity to the reintroduction of wildtype pRb, have been the cells of choice for testing pRb biological activity, these cells are not representative of cells in general. By making use of cells with a more normal genetic make-up and which contain functioning wildtype pRb, the assay presented in this paper may re¯ect a more generalized situation and may be useful as a tool to further study the role of pRb in the cell.
Materials and methods
Plasmid constructs
pTool was constructed as a synthesis of the pSPT19 vector (Boehringer-Mannheim, Indianapolis, IN) and the RB1-cDNA portion of p7ZF7SS (a generous gift from Dr R Takahashi). The N-terminus mutant (N) was constructed by digesting pTool with AccI and BsmI and inserting an adapter with AccI and BsmI compatible cohesive ends anking a FLAG-epitope sequence (Hopp et al., 1988) with an additional termination (TGA) codon. Because the Nterminus mutant lacked a nuclear localization signal, another version with the SV40 Nuclear Localization Signal (NLS) (Dingwall and Laskey, 1991) (N-NLS) was constructed by ®rst digesting pTool with AccI and BsmI and then religating with an adapter containing the SV40 T antigen NLS (5'-CCAAAAAAGAAGAGAAAGGTAC-GAATG-3') (peptide sequence PKKKRKV)¯anked by AccI and BsmI compatible cohesive ends. The resulting mutant was then digested with BsmI and MfeI and religated with an adapter coding for FLAG with a STOP codon and¯anked by BsmI and MfeI cohesive ends. The C-terminus mutant (C) was constructed by digesting pTool with XhoI and SspI and ligating in an adapter which maintained the XhoI site and added an initiation codon (ATG) 5' to a FLAG-epitope sequence. The pocket-alone mutant (A+B) was constructed by partially digesting pTool with EcoRI and fully digesting with XhoI. the digested pTool was then ligated together using an adapter with a 5' cohesive compatible XhoI site which maintained the site, an initiation codon, a FLAG-epitope sequence, and a 3' EcoRI cohensive compatible end to generate an Ntruncated mutant (A/B+C). The A/B+C construct was then digested with MfeI, which cuts at nucleotides 2643 in the translated region and 3073 in the 3' untranslated region. Re-ligation of the MfeI ends which have been made blunt by digestion with Mung Bean nuclease produced an in-frame stop codon within 3 codons. Each RB1 cDNA was transferred into pEBS7, a mammalian expression vector containing the drug selectable markers for ampicillin resistance and hygromycin B resistance (Peterson and Legerski, 1991) , by ligating the XhoI/NotI fragment from pTool into the pEBS7 polylinker, which is anked by the CMV constitutive promoter and the b-globin poly(A) + sequence. For inducible expression of the RB1 mutants, the mutant cDNAs were transferred to pTB (ATCC 77386), which contains the metallothionein promoter. The RB1 cDNAs were excised from the pEBS7 constructs by XbaI and inserted into the SpeI site of pTB. The mutant constructs, those in both pEBS7 and pTB, were linearized by digestion with BamHI.
Large scale plasmid puri®cation was accomplished by utilizing Qiagen Plasmid Kits according to manufacturer's instructions (Qiagen, Chatsworth, California).
Cell culture and DNA transfections
Mv1Lu cells (Mink lung epithelium, ATCC CCL 64) were incubated at 378C in a 5% CO 2 atmosphere. These cells were cultured in Minimal Essential Media (MEM) with Earle's salts supplemented with 1% Pen-Strep, 1% MEM non-essential amino acids, 1% MEM sodium pyruvate, and 10% fetal bovine serum (FBS). Stable transformants were selected using concentration of 300 mg/ml hygromycin (Calbiochem, La Jolla, California). All transfections were performed using the Bio-Rad Gene Pulser electroporator with capacitance extender (Bio-Rad, Richmond, California) at 2000V and 25 mF on 1610 7 cells brought to a total volume of 800 ml with PBS. Experiments were performed with 40 ± 60 mg total DNA. pTB does not carry a drug resistance marker suitable for selection in eukaryotic cells; therefore, constructs within the pTB vector were cotransfected 4 : 1 with pEBS7, which contains the hygromycin resistance gene. To induce expression of the pTB constructs, transfected Mv1Lu cells were fed with media containing 100 mM ZnCl 2 and 0.2% FBS for the indicated times. Expression of each mutant protein in the individual cell populations was veri®ed by immunoperoxidase staining with the anti-FLAG M2 antibody (IBI-Kodak, New Haven) (data not shown).
Immuno¯uorescence
Cells were grown on chamber slides (Nunc; Naperville, Illinois) for 48 h. The slides were then rinsed brie¯y in PBS, ®xed in cold 100% methanol for 10 min, air dried, and rehydrated in two changes of PBS over 20 min. The rehydrated slides were then incubated in 50% goat serum for 30 min at room temperature. The slides were blotted, and the dilute primary antibody (either anti-FLAG M2 mouse monoclonal IgG 1 (IBI-Kodak; Rochester, New York), at a 1 : 100 dilution of a 100 mg/ml stock, or anti-RB1 mouse monoclonal IgG 1 MAb1 (Triton Diagnostics; Alameda, California), at a 1 : 200 dilution of a 100 mg/ml stock) was applied. The slides were incubated at 48C overnight. The slides were rinsed in buer three times for 10 min each, excess buer was wiped o, and Texas Red Goat anti-Mouse IgG was applied at a concentration of 5 mg/ml. The slides were incubated at room temperature for 2.5 h. The slides were then rinsed in three changes of PBS for 10 min each. One of these PBS rinses contained 1 mg/ml Hoechst 33258 as a counterstain used to visualize DNA. After counterstaining, all slides were coverslipped using an aqueous mounting media.
Crystal violet staining
Cells attached to T75¯asks were ®xed with 100% Methanol for 10 min at room temperature and subsequently air dried. The dried cells were stained with a 1% aqueous crystal violet solution for 10 min at room temperature, rinsed brie¯y with distilled water, then air dried.
Western analysis
Cells were grown for 96 h following induction (or replating for controls). The cells were then removed by trypsinization, washed two times with phosphate-buered saline and resuspended in 500 ml of lysis buer (25 mM Tris, pH 7.5, 50 mM NaCl, 0.5% sodium deoxycholate, 0.1% SDS, and 0.2% Nonidet P-40) supplemented with protease inhibitors (10 mg/ml 1,10-phenanthroline, 10 mg/ml aprotinin, 10 mg/ ml leupeptin, 1 mM phenylmethylsulfonyl¯uoride), and phosphatase inhibitors (10 mM sodium¯uoride, 10 mM sodium phosphate, 10 mM sodium pyrophosphate). After 40 min of incubation, the cells were vortexed brie¯y, centrifuged at 15 000 r.p.m. for 10 min at 48C followed by ®ltration through a 0.45 mm syringe ®lter and the supernatant retained for analysis. Protein concentrations were determined by the Bradford assay (Bio-Rad) according to the manufacturer's instructions. 100 mg of whole-cell extract from each of the cultures was used in each lane. The protein was loaded on a 7% SDS-polyacrylamide gel and electrophoresed for 45 min at 195V. The proteins were transferred to nylon-reinforced nitrocellulose (Schleicher and Schuell; Keene, New Hampshire) using a semi-dry electroblotter (Bio-Rad) according to the manufacturer's instructions. The membrane was removed from the electroblotter and blocked by pre-hybridization with 16BLOTTO (Pierce, Rockford, IL) for 30 min. The membrane was then washed brie¯y in TBS and the primary antibody added (1 mg anti-FLAG M2 mouse monoclonal IgG 1 (IBI-Kodak; Rochester, New York) and 1 mg each of anti-RB1 antibodies 1F8 and C-15 (Santa Cruz Biotech; Santa Cruz, California) in 4 ml BLOTTO) and incubated overnight. The membrane was then washed in TBS + 0.05% Tween-20 and the secondary antibody added (0.2 mg peroxidase conjugated goat anti-mouse IgG 1 plus 0.2 mg peroxidase conjugated goat anti-rabbit IgG 1 in 10 ml BLOTTO) and incubated for 60 min. The speci®c proteins were then visualized using the chemoluminescent SuperSignal CL-HRP Substrate System (Pierce, Rockford, Illinois) according to the manufacturer's protocol. The blots were exposed to X-ray ®lm for 30 ± 180 s.
Isolation of DNA for DNA-fragmentation analysis
Attached cells were removed from tissue culture¯asks by trypsinization and combined with the supernatant from their respective¯asks. The cells were pelleted by centrifugation at 1200 r.p.m. for 5 min. The pellet was washed in 10 ml PBS and re-centrifuged. The cells were lysed in 5 ml of lysis buer (0.075 M NaCl, 0.024 M EDTA) with 500 ml 10% Sarkosyl and 100 ml of 20 mg/ml proteinase K at 48C overnight. After phenol/chloroform extraction, the DNA/RNA was precipitated in 0.5 M NaCl-50% isopropranol (®nal concentration) and centrifuged at 10 000 r.p.m. for 20 min at 48C. The RNA was digested by the addition of 60 mg/ml RNaseA and incubation at 378C for 30 min. After re-extraction with phenol : chloroform, chloroform, and ethanol reprecipitation, the pellet was dissolved in an appropriate volume of TE. To visualize laddering, the DNA was electrophoresed on a 1% agarose gel and stained with ethidium bromide.
